CD274 and Epstein-Barr virus infection: It has been shown in multiple tumors, indexes such as PD‐L1 positivity, dMMR/MSI, and EBV infection are benefitable biomarkers from ICI therapy, yet TMB has not been considered valid in instructing immunotherapy in GC.59, 60, 61